Geode Capital Management, LLC Protara Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.52 Trillion
Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 758,719 shares of TARA stock, worth $4.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

758,719

Previous 744,519 1.91%

Holding current value

$4.18 Million

Previous $2.26 Million 46.34%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$2.78 - $4.41 $39,476 - $62,622	14,200 Added 1.91%	758,719 $3.3 Million
Q2 2025 Aug 08, 2025	BUY	$2.88 - $4.42 $1.15 Million - $1.76 Million	397,822 Added 114.75%	744,519 $2.26 Million
Q1 2025 May 13, 2025	BUY	$3.37 - $6.14 $563,140 - $1.03 Million	167,104 Added 93.05%	346,697 $1.48 Million
Q4 2024 Feb 12, 2025	BUY	$1.68 - $7.53 $16,049 - $71,934	9,553 Added 5.62%	179,593 $942,000
Q3 2024 Nov 12, 2024	BUY	$1.7 - $2.4 $50,173 - $70,833	29,514 Added 21.0%	170,040 $311,000

Q2 2024 Aug 09, 2024	BUY	$1.96 - $4.14 $112,933 - $238,542	57,619 Added 69.5%	140,526 $292,000
Q1 2024 May 13, 2024	BUY	$1.86 - $4.83 $8,163 - $21,198	4,389 Added 5.59%	82,907 $332,000
Q3 2023 Nov 13, 2023	SELL	$1.64 - $2.93 $8,039 - $14,362	-4,902 Reduced 5.88%	78,518 $131,000
Q4 2022 Feb 13, 2023	SELL	$2.43 - $3.7 $544 - $828	-224 Reduced 0.27%	83,420 $223,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $5.33 $4,704 - $8,954	1,680 Added 2.05%	83,644 $245,000
Q1 2022 May 13, 2022	BUY	$4.19 - $6.9 $12,347 - $20,334	2,947 Added 3.73%	81,964 $418,000
Q3 2021 Nov 12, 2021	SELL	$6.38 - $9.3 $25,315 - $36,902	-3,968 Reduced 4.78%	79,017 $546,000
Q2 2021 Aug 13, 2021	SELL	$8.68 - $16.99 $243,708 - $477,028	-28,077 Reduced 25.28%	82,985 $808,000
Q1 2021 May 12, 2021	BUY	$13.75 - $23.86 $85,002 - $147,502	6,182 Added 5.89%	111,062 $1.75 Million
Q4 2020 Feb 12, 2021	BUY	$16.97 - $25.34 $1.44 Million - $2.14 Million	84,598 Added 417.11%	104,880 $2.54 Million
Q3 2020 Nov 13, 2020	BUY	$16.76 - $31.89 $47,564 - $90,503	2,838 Added 16.27%	20,282 $341,000
Q2 2020 Aug 13, 2020	BUY	$22.0 - $60.7 $383,768 - $1.06 Million	17,444 New	17,444 $511,000

Others Institutions Holding TARA

# of Institutions

Shares Held

24.3M

Call Options Held

13K

Put Options Held

46.4K

View Full List

About Protara Therapeutics, Inc.

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $62.1M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

More about TARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Protara Therapeutics, Inc. Transaction History